A calm, sunlit institutional interior with a potted olive tree on a travertine counter
Healthcare · AYMI

Healthcare growth marketing, regulated by design.

AYMI is the growth and performance marketing partner for regulated healthcare — providers, payers, pharma, and biotech. Healthcare is not consumer DTC with disclaimers attached; it's its own discipline of long cycles, high trust, and audiences that buy with their professional license, not just their wallet. We build the engagement that compounds inside the constraint.

In one line

AYMI is a growth and performance marketing agency for regulated healthcare — providers, payers, pharma, and biotech. We build multi-stakeholder growth systems across HCP, patient, and payer audiences, with measurement and creative engineered for the regulatory frame.

  • Built for trust

    Compliance is the operating system, not an afterthought.

  • Multi-stakeholder by design

    HCP, patient, and payer modeled as distinct audiences.

  • Regulated by design

    Creative and measurement engineered for the frame.

  • 01+310%Qualified MA leads (Florida Blue)
  • 023.4xMulti-stakeholder pipeline (UnitedHealth)
  • 03+175%Retail-health bookings (CVS Health)
What changes

What changes in healthcare.

Healthcare audiences are multi-stakeholder by structure. The HCP, the patient, and the payer all see different surfaces, sign off on different decisions, and respond to different signal. Performance frameworks built for single-stakeholder DTC funnels misallocate spend the moment they hit a regulated category. The Method runs the cadence against the stakeholder the conversion actually depends on.

Creative systems bend toward editorial-grade clinical content. Trust-led brand work. Modular architectures that let the brand ship HCP-facing, patient-facing, and payer-facing variants from a single visual system without the regulated copy slipping out of register.

Organic surfaces are KOL programs, peer-reviewed content syndication, and condition-specific community work. The work that wins healthcare is the work that respects the regulatory frame as the operating environment — not the obstacle.

Multi-stakeholder by structure, not by choice.

Healthcare brands are not short on audiences. They are short on one multi-stakeholder system.

Healthcare and pharma brands already have the audiences: HCPs, patients, caregivers, and payers — each with its own channels, compliance frame, and buying logic. The problem is that most growth programs run a single-stakeholder funnel and misallocate spend inside a regulated category where the decision is shared.

AYMI builds the system that models each stakeholder as a distinct audience and connects them — so HCP engagement, patient demand, and payer pipeline move together toward a conversion no single audience controls.

  • HCP engagement becomes a modeled input, not a separate silo.
  • Patient-condition demand becomes compliant, audience-cut creative.
  • Caregiver intent becomes its own qualified-lead surface.
  • Payer interest becomes a pipeline signal, not an afterthought.
  • Regulatory constraints become the creative frame, not the blocker.
  • Converted patients become the adherence and retention base.
One connected stakeholder loop
  1. 01Awareness
  2. 02HCP
  3. 03Patient
  4. 04Payer
  5. 05Conversion
  6. 06Adherence
The decision layer

Where AYMI plugs in.

AYMI fits best when the organization already has the fundamentals: an approved product or service, a compliance process, stakeholder-specific content, and internal teams driving the brand.

We add the system that models HCP, patient, and payer as distinct audiences — the audience design, the spend allocation, and the measurement that decides where regulated spend goes.

  • 01

    Which stakeholder actually controls the conversion?

  • 02

    Which HCP engagement is moving patient demand downstream?

  • 03

    Which patient-condition audiences clear compliance and convert?

  • 04

    Which creative frame works inside the regulatory constraint?

  • 05

    Which channels deliver qualified leads by stakeholder?

  • 06

    Where does payer pipeline sit relative to patient demand?

  • 07

    Which converted patients should be supported into adherence?

Start with one product, one condition, or one stakeholder.

The Multi-Stakeholder Growth Sprint

A focused 30-day engagement to map HCP, patient, and payer signal into one compliant growth system — for a healthcare, pharma, or digital-health brand.

Not a full retainer. A focused sprint that shows where stakeholder modeling, compliant creative, and measurement make regulated growth measurable across the audiences the conversion depends on.

Best for
  • Pharma and biotech
  • Digital health
  • Medical devices
  • Provider networks
  • Payers and plans
  • Health and wellness
What you get in 30 days
  • Multi-stakeholder audience map across HCP, patient, caregiver, and payer
  • Compliance-aware funnel audit by stakeholder
  • Paid media test plan across compliant Meta, Google, and endemic channels
  • Regulatory-frame creative map for each stakeholder audience
  • Stakeholder-weighted attribution model toward shared conversion
  • Stakeholder dashboard for qualified-lead cost, engagement, and pipeline
  • 30-day action plan for scaling across stakeholders
The services, in healthcare

Performance systems for every stakeholder in the care journey.

  1. Awareness
  2. HCP
  3. Patient
  4. Payer
  5. Conversion
  6. Adherence
  • Multi-Stakeholder Modeling

    HCP, patient, caregiver, and payer modeled as distinct audiences with distinct logic — instead of one funnel that misallocates spend across all four.

  • Regulated Creative Systems

    Creative and messaging engineered for the regulatory frame from the start — compliance as the operating system, not a final-step blocker.

  • HCP Engagement

    Endemic and targeted programs that move clinician engagement — measured as an input to downstream patient demand, not a separate silo.

  • Patient & Caregiver Demand

    Condition-aware, compliant demand generation for patients and caregivers — audience-cut creative that clears the frame and still converts.

  • Payer Pipeline

    Payer and plan engagement built as its own pipeline surface, connected to patient demand rather than run in isolation.

  • Measurement Layer

    Dashboarding around qualified-lead cost by stakeholder, HCP engagement, patient-condition demand, and payer pipeline.

From reach to qualified demand.

Every regulated dollar should move the stakeholder the conversion depends on.

In healthcare, reach is easy and the conversion is shared across stakeholders who each see a different message. A single-stakeholder funnel almost always misallocates the budget.

AYMI helps organizations understand which stakeholders, conditions, and channels are actually creating qualified, compliant demand — then turns those signals into multi-stakeholder media decisions.

Stakeholder signal panel
  • 01Cost per qualified lead by stakeholder
  • 02HCP engagement rate
  • 03Patient-condition demand
  • 04Caregiver lead quality
  • 05Payer pipeline contribution
  • 06Compliant-audience reach
  • 07Stakeholder-weighted conversion
  • 08Adherence / retention rate
  • 09Geo-level demand
  • 10Blended cost per conversion
Selected work

Healthcare × AYMI.

See all healthcare work →
The pillar

Read the argument behind the work.

No. 041Strategy

Healthcare growth, regulated by design

Healthcare is not consumer DTC with disclaimers attached. It is its own discipline — multi-stakeholder, long-cycle, and regulated by design rather than by accident.

Read the pillar
Healthcare · FAQ

Questions we’re asked, answered directly.

The ones that come up most in first conversations — answered straight, without the sales gloss.

  • Yes. AYMI's healthcare practice is built for providers, payers, pharma, and biotech — regulated categories where communication is constrained and conversion depends on multiple stakeholders signing off. It applies the same growth system proven across our gaming, DTC, and entertainment work to the healthcare frame.

Next move

Building inside healthcare?

Provider, payer, pharma, or biotech — if the brief is regulated, the conversation starts here.